John ShakowPartner at King & Spalding LLPSpeaker
Profile
John’s practice focuses on complex regulatory, commercial, and litigation issues related to all aspects of drug pricing and government program liability mitigation. He has counseled pharmaceutical and biotechnology clients on their rights and obligations under the Medicaid, 340B, Medicare, Federal Supply Schedule, and TRICARE programs for over 20 years. He has extensive experience helping clients address strategic, organizational, and legal challenges while maintaining the integrity of their price reporting compliance efforts.
Agenda Sessions
HHS Drug Pricing Regulatory Agenda (Proposed): Ten Recommended Policy Initiatives for CMS and HRSA
, 8:55amView SessionGP Compliance Case Study
, 11:00amView Session